JP2013513086A5 - - Google Patents

Download PDF

Info

Publication number
JP2013513086A5
JP2013513086A5 JP2012529920A JP2012529920A JP2013513086A5 JP 2013513086 A5 JP2013513086 A5 JP 2013513086A5 JP 2012529920 A JP2012529920 A JP 2012529920A JP 2012529920 A JP2012529920 A JP 2012529920A JP 2013513086 A5 JP2013513086 A5 JP 2013513086A5
Authority
JP
Japan
Prior art keywords
subject
progression
threshold
stage
measured concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012529920A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013513086A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/049234 external-priority patent/WO2011035097A1/en
Publication of JP2013513086A publication Critical patent/JP2013513086A/ja
Publication of JP2013513086A5 publication Critical patent/JP2013513086A5/ja
Pending legal-status Critical Current

Links

JP2012529920A 2009-09-18 2010-09-17 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 Pending JP2013513086A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US24399509P 2009-09-18 2009-09-18
US24400009P 2009-09-18 2009-09-18
US61/243,995 2009-09-18
US61/244,000 2009-09-18
US25463609P 2009-10-23 2009-10-23
US61/254,636 2009-10-23
PCT/US2010/049234 WO2011035097A1 (en) 2009-09-18 2010-09-17 Methods and composition for diagnosis and prognosis of renal injury and renal failure

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015038493A Division JP2015129764A (ja) 2009-09-18 2015-02-27 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物

Publications (2)

Publication Number Publication Date
JP2013513086A JP2013513086A (ja) 2013-04-18
JP2013513086A5 true JP2013513086A5 (enExample) 2013-10-31

Family

ID=43759017

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012529920A Pending JP2013513086A (ja) 2009-09-18 2010-09-17 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
JP2015038493A Pending JP2015129764A (ja) 2009-09-18 2015-02-27 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
JP2016085091A Expired - Fee Related JP6403712B2 (ja) 2009-09-18 2016-04-21 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015038493A Pending JP2015129764A (ja) 2009-09-18 2015-02-27 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
JP2016085091A Expired - Fee Related JP6403712B2 (ja) 2009-09-18 2016-04-21 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物

Country Status (10)

Country Link
US (2) US20130045494A1 (enExample)
EP (2) EP2470904A4 (enExample)
JP (3) JP2013513086A (enExample)
CN (2) CN105004864B (enExample)
AU (2) AU2010295512B2 (enExample)
CA (1) CA2773905A1 (enExample)
EA (1) EA201290106A1 (enExample)
MX (1) MX2012003168A (enExample)
NZ (2) NZ598741A (enExample)
WO (1) WO2011035097A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2721907T3 (es) * 2011-08-26 2019-08-06 Astute Medical Inc Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
JP6532460B2 (ja) * 2013-07-26 2019-06-19 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 患者モニタリングシステムに関する臨床規則及び規定のコンピュータ化及び視覚化
GB201501597D0 (en) * 2015-01-30 2015-03-18 Randox Lab Ltd Thrombomodulin
CN108271422A (zh) 2015-06-25 2018-07-10 株式会社国际电气通信基础技术研究所 基于器官间串扰系统的预测装置及预测程序
WO2017130985A1 (ja) * 2016-01-29 2017-08-03 株式会社国際電気通信基礎技術研究所 腎機能の評価装置、腎疾患の合併症の発症の予測装置、およびリン摂取量推定装置
JP6432962B2 (ja) 2016-03-29 2018-12-05 株式会社国際電気通信基礎技術研究所 腎機能低下、慢性腎疾患及び腎不全からなる群から選択される少なくとも一種の疾患を予防、又は治療するための有効成分の候補物質のスクリーニング方法
JP6332780B2 (ja) 2016-03-29 2018-05-30 株式会社国際電気通信基礎技術研究所 医薬組成物又は食品組成物、及び有効成分の体内での効果の評価方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
JPH0736019B2 (ja) * 1989-12-27 1995-04-19 富士薬品工業株式会社 新規な抗ヒトトロンボモジュリンモノクローナル抗体によるヒトトロンボモジュリンおよびその分解産物の定量方法
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
WO1992005282A1 (en) 1990-09-14 1992-04-02 Biosite Diagnostics, Inc. Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
ATE177841T1 (de) 1991-04-10 1999-04-15 Biosite Diagnostics Inc ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung
EP0579767B1 (en) 1991-04-11 2000-08-23 Biosite Diagnostics Inc. Novel conjugates and assays for simultaneous detection of multiple ligands
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5885527A (en) 1992-05-21 1999-03-23 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
CN1129666C (zh) * 1994-12-13 2003-12-03 人体基因组科学有限公司 金属蛋白酶－4的人组织抑制剂
CN1495258A (zh) * 1994-12-13 2004-05-12 人体基因组科学有限公司 金属蛋白酶-4的人组织抑制剂
US6544761B2 (en) * 1994-12-13 2003-04-08 Human Genome Sciences, Inc. Human tissue inhibitor of metalloproteinase-4
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
WO2001042438A2 (en) * 1999-12-13 2001-06-14 Regents Of The University Of Minnesota Leukolysin/mmp25/mt6-mmp
JP2004535765A (ja) * 2000-12-07 2004-12-02 カイロン コーポレイション 前立腺癌においてアップレギュレートされた内因性レトロウイルス
CA2453538A1 (en) * 2001-07-12 2003-01-23 Kyowa Medex Co., Ltd. Method for determination of denatured lipoprotein, reagent for determination of denatured lipoprotein, method for detection of cardiovascular disease, and reagent for detection ofcardiovascular disease
EP1742650A1 (en) * 2004-03-30 2007-01-17 Den Kgl.Veterin R-Og Landboh Jskole Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and detecting protease inhibitors
US7713693B1 (en) * 2004-09-01 2010-05-11 University Of Louisiana At Monroe Human cancer cell specific gene transcript
US20060160112A1 (en) * 2004-12-02 2006-07-20 Erdal Cavusoglu Tissue inhibitor of metalloproteinase (TIMP) as a marker and predictor of cardiovascular disease and both cardiac and non-cardiac mortality
US20090178145A1 (en) * 2005-05-11 2009-07-09 The Procter & Gamble Company Methods and targets for identifying compounds for regulating angiogenesis
WO2007053610A2 (en) * 2005-11-01 2007-05-10 The Regents Of The University Of California Methods of treating atrial fibrillation wtih pirfenidone
JP2007163151A (ja) * 2005-12-09 2007-06-28 Kitasato Gakuen 対象生物の生理状態を判定する方法
AU2007249620A1 (en) * 2006-05-09 2007-11-22 Musc Foundation For Research Development Detecting diastolic heart failure by protease and protease inhibitor plasma profiling
CN101490273A (zh) * 2006-05-09 2009-07-22 南卡罗来纳州医科大学研究发展基金会 利用蛋白酶和蛋白酶抑制剂血浆分析检测舒张期心力衰竭
WO2008084331A2 (en) * 2006-06-21 2008-07-17 Hopitaux Universitaires De Geneve Biomarkers for renal disorders
RU2009104460A (ru) * 2006-07-11 2010-08-20 Маск Фаундейшн Фор Рисерч Дивелопмент (Us) Прогнозирование сердечной недостаточности после инфаркта миокарда по профилю протеаз и ингибиторов протеаз
GB0617429D0 (en) * 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
EP2095107B1 (en) * 2006-11-14 2014-07-02 Alere San Diego, Inc. Methods for risk assignment
FR2909180B1 (fr) * 2006-11-29 2009-02-20 Diagnostica Stago Soc Par Acti Methode de mesure fonctionnelle de l'activite de la thrombomoduline plasmatique.

Similar Documents

Publication Publication Date Title
JP2013503344A5 (enExample)
JP2016505143A5 (enExample)
JP2013519095A5 (enExample)
JP2013501920A5 (enExample)
JP2014529073A5 (enExample)
JP2012517594A5 (enExample)
JP2012517592A5 (enExample)
JP2015129764A5 (enExample)
JP2013513086A5 (enExample)
JP2013515243A5 (enExample)
Xie et al. Tissue inhibitor metalloproteinase-2 (TIMP-2)• IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury
HRP20160733T1 (hr) Postupci i pripravci za postavljanje dijagnoze i prognoze ozljede bubrega i bubrežne insuficijencije
JP2013531240A5 (enExample)
JP2013510321A5 (enExample)
US9551720B2 (en) Urine biomarkers for prediction of recovery after acute kidney injury: proteomics
JP2013539861A5 (enExample)
JP2013510322A5 (enExample)
JP4879993B2 (ja) Ｎｇａｌを使用する慢性腎疾患の診断および監視
JP2017533427A5 (enExample)
JP2021039112A5 (enExample)
JP2014521088A5 (enExample)
US20200271669A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
TR201807542T4 (tr) Böbrek hasarı ve böbrek yetmezliği teşhisi ve prognozuna yönelik metotlar ve bileşimler.
WO2013086359A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2017214203A1 (en) Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2